result in leucoerythroblastic anxmia, which in fact is found in less than 50% of these patients.
Marrow occupation would also depress yG first, as shown in Group C, whereas this is usually the last to fall. Furthermore, yA is largely derived from the gut which is rarely directly involved by tumour. It has also been suggested that the neoplastic cells misappropriate available amino acids at the expense of normal plasma cells. Immunoglobulin deficiency is, however, unusual with most other types of neoplasia and even among the reticuloendothelial malignancies it cannot be correlated with the extent of the tumour. These theories also fall down with localized tumours which can be associated with immunoglobulin deficiency. In two patients removal of an apparently solitary myeloma was found to restore immunoglobulin levels to normal (Hobbs 1966) . In 2 other patients with severe hypogammaglobulinemia (yG 160, 140 mg/100 ml) and gross splenomegaly, splenectomy was followed by recovery of yG levels (500, 800 mg/100 ml). In these 2 cases, which are very much the exception, histology revealed giant follicular lymphomatosis of the spleen, quite distinct from the hyperplasia typical of adult hypogammaglobulinemia. Neither patient has yet shown metastases at two and three years respectively. The findings in the above 4 patients suggest that reticuloendothelial tumouis can release some humoral substance which can inhibit the synthesis of normal immunoglobulins.
Throughout the above discussion it has been assumed the reticuloendothelial malignancy came first, and indeed the picture of worsening hypogammaglobulinemia with longer duration of disease suggests this is the usual pattern. However, it is also possible that hypogammaglobulinaemia itself results in overstimulation of the cellular mechanisms of immunity to a degree increasing the risk of neoplastic mutation. Recently Fudenberg (1966) has reviewed the evidence which supports the belief that antibody deficiency can sometimes be primary to reticuloendothelial neoplasia.
In summary, secondary immunoglobulin deficiency is much commoner than the primary types and an important mechanism for symptoms in 1 % of hospital patients. It can be classified into five rtiological categories the first three of which largely affect only yG levels, the latter two characteristically reducing yM initially, then yA and finally yG. Diagnosis and treatment with y-globulin is especially rewarding in the physiological group and can be helpful with marrow disorders and with the more slowly progressive reticuloendothelial malignancy. 
Combined Cellular and Humoral Deficiency States
A classification of diseases due to deficiencies of immune mechanisms is given by Soothill (1968) . I review here some of the clinical observations on which this attempt at classification is based. It refers mostly to congenital deficiencies with manifestation in early life, quite often genetically transmitted and seen predominantly by the peediatrician. The leading clinical sign of all these diseases is increased susceptibility to and abnormal reaction against infections.
The first clear-cut disease entity in this group was described in 1952 by Bruton and by Janeway et al. (1953) under the designation 'congenital agammaglobulinemia'. The clinical appearance is explained by a complete deficiency of the humoral defence mechanisms with severe diminution of all classes of immunoglobulins. The genetic transmission is of the sex-linked type. The prognosis is fairly good, if appropriate replacement therapy with immunoglobulin concentrates is given. Several hundred boys with this disease have been described in the literature.
bodies, but also the fact that stimulation of their blood lymphocytes by antigens or by phytohimagglutinin is not answered by transformation, proliferation or differentiation of these cells. Moreover, all the tests used for evaluation of delayed hypersensitivity reactions are negative, and transplantation immunity is virtually absent.
Within the last ten years we and our colleagues have fully investigated 14 patients who meet the In 1964 Nezelof et al. described a third type of predominantly cellular immunodeficiency disease with normal levels of immunoglobulins, but very low numbers of circulating lymphocytes in which the histology of the lymphatic tissue and the thymus is similar to that seen in the combined immunodeficiency syndrome. Within the last two or three years a few more cases of this type have been described. We have seen one family with two affected boys, in one of whom a full evalua-20 tion of immunological function was possible. In spite of normal levels of immunoglobulins no formation of specific antibodies after repeated antigenic stimulation was noted.
A distinct group of lymphopenia was described by DiGeorge et al. (1968) : in these patients multiple malformations (aplasia of thymus and parathyroids and hypoplasia of the mandibula) arise from a suppressed development of the 3rd and 4th branchial pouch. The clinical appearance in the first days of life is marked by signs of hypoparathyroidism with tetanic convulsions; if the patients survive this critical phase, lymphocytic incompetence is manifested later.
In Table 1 the criteria for a differentiation of the 3 types are listed.
In addition to these clear-cut disease entities several less well defined but similar clinical conditions have been described. The common denominator is the deficiency of distinct, but not of all immunological functions. Of the numerous theoretically possible combinations about a dozen have been observed in clinical cases. Dissociated defects of immunoglobulins have been designated as 'dysgammaglobualinemia' (Rosen et al. 1961) or 'dys-immunoglobulinaemia' (Stoelinga 1966) . Frequently these seem to be associated with inability to form humoral antibodies or 'antibody deficiency syndrome'. For detection of analogous deficiencies of lymphoid cells the diagnostic means are less well developed. The situation seems clear in severe lymphopenia, but functional incompetence of lymphocytes ('dyslymphocytosis') is more difficult to prove.
In general, the clinical symptomatology is less severe in the isolated dys-immunoglobulinwmias and the effect of replacement therapy is quite good. On the other hand, in all the combinations including cellular anomalies severe disease manifestations are seen that can scarcely be ameliorated by any treatment available so far.
Extensive study of patients with congenital immunodeficiencies is not only of practical value for better treatment of an individual patient, but has also contributed to the theoretical understanding of immune mechanisms in general.
DrHEMKay (Royal Marsden Hospital and Institute ofCancer Research, London)
The Thymus in Immune Deficiency In mammals the thymus alone fulfils the criteria for a 'primary' or 'central' lymphoid organ (Good et al. 1966 , Miller & Osoba 1967 , Evans et al. 1967 . At a stage after its formation from the branchial endoderm it appears to act as a relay station for cells which quit the thymus for the peripheral lymphoid organs. Its function in this cellular pathway may depend upon cellular proliferation, on the generation of diversity among immunocytes or on an endocrine effect. The occurrence of immune deficiency syndromes, and the circumstance in some that foreign tissues are tolerated, afford a unique opportunity for therapy and for determining the primary sites of the defects by organ transplantation.
In the DiGeorge syndrome it is likely that the absence of the thymus is the primary and sole cause of the immune defect (DiGeorge et al. 1968 ); replacement should cure. In other syndromes a histologically normal thymus probably indicates that the defect is in the peripheral lymphoid tissues; an abnormal thymus, however, such as is seen in the Swiss type of immune deficiency, may equally well be due to a defect of branchial thymic cells or to a failure, later in development, of immigrant stem cells. Either may, of course, result from an extrinsic primary ietiological event --virus infection, attack by maternal lymphocytes or a remote biochemical defect.
